Altre lingue OSL Group Limited

Azioni

863 KYG1106B1095

Tempo differito Hong Kong S.E. Altri mercati azionari 07:35:43 26/04/2024			Variaz. 5gg	Var. 1 gen.
9,93 ^HKD	+1,85%		+3,44%	-18,34%

19/04	OSL Group Limited annuncia le dimissioni di Yang Yu da Amministratore indipendente non esecutivo	CI
10/04	OSL sarebbe il principale concorrente per le attività europee di Ted Baker	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

OSL Group Limited Announces the Resignation of Yang Yu as Independent Non-Executive Director	19/04
OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial	18/04
Solowin Unit Chosen as Participating Dealer for Spot Bitcoin, Ethereum ETF in Hong Kong	16/04
OSL Arm to Provide Trading Platform for ChinaAMC's Spot Bitcoin ETFs	16/04
OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device	16/04
OSL : Appointed as the First Exchange and Sub-Custodian Partner for China AMC’s Inaugural Spot BTC/ETH ETF Launch in Hong Kong	15/04
OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study	12/04
OSL Said to Be Leading Contender for Ted Baker’s European Business	10/04
OncoSil Medical Obtains Device Reimbursement Approval in UK	09/04
OSL : Monthly Investor Update	05/04
First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device	05/04
OSL Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus	25/03
Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer	20/03
OSL : Monthly Investor Update	05/03
Hainan Wanruntong Information Technology Co., Ltd announced that it has received funding from HongShan, OSL Group Limited, Animoca Brands Limited	22/02
OSL to Participate in Pilot Investment-Grade Tokenized Warrant Issuance of UBS	07/02
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade	01/02
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%	01/02
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%	01/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue OSL Group Limited

Azioni

863

KYG1106B1095

Altre lingue

Filtri